AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors
Another Week, Another Index Record | Lkive Stock
ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline
AbbVie (ABBV.US) has reached an acquisition agreement to expand its presence in the field of autoimmune diseases.
AbbVie (ABBV.US) announced that it has reached a final agreement with Nimble Therapeutics.
EMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's Disease
AbbVie Announces Leadership Change With New Appointment
